These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32375371)

  • 21. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson's disease.
    Troshev D; Berezhnoy D; Kulikova O; Abaimov D; Muzychuk O; Nalobin D; Stvolinsky S; Fedorova T
    Brain Res Bull; 2021 Aug; 173():1-13. PubMed ID: 33892082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
    Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
    Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenothiazine normalizes the NADH/NAD
    Tapias V; McCoy JL; Greenamyre JT
    Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.
    Drolet RE; Cannon JR; Montero L; Greenamyre JT
    Neurobiol Dis; 2009 Oct; 36(1):96-102. PubMed ID: 19595768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
    Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
    Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM; Sherer TB; Greenamyre JT
    Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.
    Murakami S; Miyazaki I; Miyoshi K; Asanuma M
    Neurochem Res; 2015 Jun; 40(6):1165-78. PubMed ID: 25894684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
    Sakamula R; Yata T; Thong-Asa W
    Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and Enteric Neuroprotective Effects by Eucommia ulmoides Extracts on Neurodegeneration in Rotenone-induced Parkinsonian Mouse.
    Imafuku F; Miyazaki I; Sun J; Kamimai S; Shimizu T; Toyota T; Okamoto Y; Isooka N; Kikuoka R; Kitamura Y; Asanuma M
    Acta Med Okayama; 2022 Aug; 76(4):373-383. PubMed ID: 36123151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Reproducibility of Oral Rotenone as a Model for Parkinson's Disease in Mice.
    Niederberger E; Wilken-Schmitz A; Manderscheid C; Schreiber Y; Gurke R; Tegeder I
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
    Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
    Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.
    Matschke LA; Komadowski MA; Stöhr A; Lee B; Henrich MT; Griesbach M; Rinné S; Geibl FF; Chiu WH; Koprich JB; Brotchie JM; Kiper AK; Dolga AM; Oertel WH; Decher N
    Sci Rep; 2022 Feb; 12(1):3180. PubMed ID: 35210472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice.
    Miyazaki I; Isooka N; Wada K; Kikuoka R; Kitamura Y; Asanuma M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.